BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T cells for the particular molecular fingerprint of each patient’s own cancer through our novel TCXpress technology. Our proprietary TCXpress platform is an elegant, rapid approach that exploits the patient’s own immune defenses to attack their cancer specifically, and is designed to leave normal tissues untouched, thereby reducing harmful side effects. The platform and implementation allows us to deliver rapid, personalized T cell treatments for a variety of cancer indications.
BlueSphere Bio Address
350 Technology Drive Pittsburgh, PA United States
BlueSphere Bio Email
Past Companies
BlueSphere BioSenior Vice President, Head of Business Development & Strategy
BlueSphere BioVice President of Business Development & Operations
BlueSphere BioExecutive Director, Business Development & Corporate Strategy